WESTWEGO, Louisiana — Robin Phillip’s fresh haircut is dyed her favorite color — green. But beneath the dye job is a scar that runs along the side of her head, the result of two craniotomies. For ...

As of 2025, lawsuits are now underway against Pfizer, the manufacturer of Depo-Provera, filed by women who were diagnosed with meningioma after using the birth control shot. These cases allege that ...

The Singleton Schreiber Law Firm is seeking individuals who developed potentially life-altering brain tumors as a result of using a popular birth control injection. Singleton Schreiber says the ...

Women across the country are taking legal action against Pfizer, the manufacturer of Depo-Provera, alleging that the company failed to warn about the risks of developing meningiomas — generally ...

The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...

U.S. District Judge M. Casey Rodgers of the Northern District of Florida is overseeing more than 400 lawsuits alleging that Depo-Provera, an injectable birth control, has caused non-malignant brain ...

The judge appointed Chris Seeger as lead counsel and co-leads Ellen Relkin and Bryan Aylstock. More than 70 lawsuits against Pfizer allege Depo-Provera, an injectable birth control, has been linked to ...

The Food and Drug Administration approved on Friday a label change for Pfizer's birth control shot Depo-Provera that warns patients of the risk of meningioma, a tumor in the lining of the brain.

Jul 24, 2025, 7:00 AM ETPfizer Inc. (PFE), PFE:CA Mahyar Etminan, one of the authors of ‘the Frey study’, said: “Given the elevated risk of meningioma with medroxyprogesterone, women may opt to ...

A popular injectable birth control, Depo-Provera (medroxyprogesterone acetate) — also sold as Depo-SubQ Provera 104 — has long been favored for its 99% effectiveness and ease of use compared to daily ...

WASHINGTON (7News) — This week, the FDA approved a label change on Depo-Provera, requiring its maker, Pfizer, to warn women about links between use of the birth control injection and brain tumors ...